Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
01/2011
01/20/2011CA2768149A1 Stereoisomer peptides and their polymer conjugates for hiv disease
01/19/2011EP2274332A1 Anti-tnf antibody
01/19/2011EP1509336B1 Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers
01/19/2011EP1411962B1 Monoclonal antibody therapy for pancreas cancer
01/19/2011CN101952432A Peptide, use of the peptide, method for production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support
01/18/2011US7872104 Antibody, immunoassay and method for prostate cancer detection
01/18/2011US7872100 Nitrile hydratases from metagenome libraries
01/18/2011US7871767 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic applications
01/18/2011US7871620 Immunoliposomes that optimize internationalization into target cells
01/18/2011CA2637795C Antagonists of interleukin-15
01/18/2011CA2191053C A fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterlogous sequence
01/13/2011US20110008811 Resin Assisted Capture of Cysteine-Modified Proteins/Peptides and Determination of Presence and Location of Modification
01/13/2011US20110006218 Nanodiamond compositions and methods of making and using thereof
01/13/2011CA2767392A1 Methods for preparing vesicles and formulations produced therefrom
01/12/2011EP2272875A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
01/12/2011EP2272865A2 Method of producing hydroxyalkyl starch derivatives
01/12/2011EP2272501A1 Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate
01/12/2011EP2272321A2 Hypersensitive response induced resistance in plants by seed treatment
01/12/2011EP2271675A2 Thrombin activator compostions and methods of making and using the same
01/11/2011US7868150 Nucleic acids encoding T2R taste receptors
01/11/2011US7868145 Magnetic particles containing a copolymer core, magnetic layer and silicon layer
01/11/2011US7868143 by which blood cells can be stimulated; amount of required mAbs is lower than when using the same mAbs in a solution, which makes the stimulation independent from the presence or the quality of non-T cells carrying Fc-receptors, and which can be prepared in an easier way under GMP conditions
01/06/2011WO2011003085A1 Hyr1 as a target for active and passive immunization against candida
01/06/2011WO2010121351A8 Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy
01/06/2011WO2010099515A3 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
01/06/2011US20110003710 Selectin ligands useful in the diagnosis and treatment of cancer
01/06/2011US20110002916 Plasmodium falciparum antigens and their vaccine and diagnostic applications
01/05/2011EP2270037A2 Hasylated Factor IX
01/05/2011EP2270036A2 Hasylated polypeptides
01/05/2011EP2270028A1 Biomolecule-immobilized carrier and method for immobilizing biomolecule on carrier
01/05/2011EP2269069A1 Use of synthetic peptide derived from zebra protein for the in vivo diagnosis of the epstein-barr virus (ebv) reactivation
01/05/2011EP2069385B1 Immobilization of membrane proteins onto supports via an amphiphile
01/05/2011CN101939339A Biomarker detection
01/04/2011US7863427 labeling haptens, immunogens
01/04/2011US7863424 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
01/04/2011CA2390141C Novel compositions and processes for improved analyte detection using hybridization assays
01/04/2011CA2132103C Encoded combinatorial chemical libraries
01/04/2011CA2129899C Dual carrier immunogenic construct
01/02/2011CA2708640A1 Amplified labeled conjugate for use in immunoassays
12/2010
12/30/2010US20100331489 Branched water-soluble polymers and their conjugates
12/30/2010US20100330033 Protein-carrier conjugates
12/29/2010WO2010150375A1 Modified biotin-conjugated protein
12/29/2010EP2265283A1 Auristatin drug linker conjugates
12/29/2010EP1812074B1 Intracellular peptide delivery
12/29/2010CA2765833A1 Modified biotin-binding protein
12/28/2010US7858679 Polymeric compositions and related methods of use
12/23/2010US20100324266 Photocleavable Protecting Groups
12/23/2010US20100322945 Immunogenic compounds and protein mimics
12/22/2010EP2263791A2 Acoustic ejection of fluids from reservoirs
12/22/2010EP2262829A1 A new type of consensus interferon and preparation method thereof
12/22/2010CN101921338A Gold-binding protein and use thereof
12/21/2010US7854945 graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils
12/21/2010CA2451909C High throughput assays for the proteolytic activities of clostridial neurotoxins
12/16/2010WO2010143983A1 Assays for serological detection of syphilis
12/16/2010WO2010142850A1 Hydrophobins for dispersing active agents
12/16/2010WO2010142035A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
12/16/2010US20100317609 Method of Producing Hydroxyalkyl Starch Derivatives
12/16/2010CA2764828A1 Hydrophobins for dispersing active agents
12/16/2010CA2764777A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
12/15/2010EP1444523B1 Screening for hepatitis c virus entry inhibitors
12/15/2010CN101918841A Peptide-lipid constructs and their use in diagnostic and therapeutic applications
12/15/2010CN101357945B Synthetic peptide coupling antigen and reagent for testing porcine circovurus type 2 specific antibody
12/15/2010CN101190409B Blood purifying protein A immunoadsorption material and synthesizing method thereof
12/14/2010US7851597 lyases enzymes obtained from transformed plant tissue expressing polynucleotide that encodes the polypeptide; improved ethanol biosynthesis, stalk and nodal strength
12/14/2010US7851591 peptide that binds to a human major histocompatibility complex class I A molecule; for treating a patient that has or is at risk of having a cell that expresses telomerase catalytic subunit (hTERT)
12/14/2010US7851155 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
12/14/2010US7850962 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease
12/09/2010US20100311945 HDM2-Inhibitor Complexes and Uses Thereof
12/09/2010US20100311080 Water-soluble nanocrystals through dual-interaction ligands
12/09/2010US20100310510 N-terminally chemically modified protein compositions and methods
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP1427750B1 Modified transferrin fusion proteins
12/08/2010CN101910202A Biocompatible three dimensional matrix for the immobilization of biological substances
12/08/2010CN101906162A Polyethylene glycol modified product of fibroblast growth factor-1 and mutant thereof
12/07/2010US7847071 Antibody purification by protein a and ion exchange chromatography
12/07/2010US7847068 Neutralizing human anti-IGFR antibody
12/07/2010US7846903 cubic liquid crystal formulation containing an amphiphilic compound such as 1-O-(5,9,13-trimethyltetradecyl)erythritol and a drug ( excluding a lysosomal enzyme) or cosmetic embedded in the cubic liquid crystal; time release agent
12/07/2010US7846656 For immobilization in polymer carriers of oligonucleotides, proteins, nucleic acids or any other molecules, which structure comprises active groups, including amino- or sulfhydryl groups; for microchips, dna sequencing
12/07/2010US7846449 Modified Dermatophagoides pteronyssinus allergen Der p 5 protein which inhibits immunoglobulin E (IgE) binding when exposed again to the antigen; treating allergies
12/07/2010US7846448 Lolium perenne (Lol p 1) polypeptide for use as diagnostic/prognostic indicator or allergic reactions
12/07/2010US7846433 Methods of treating pre-eclampsia and eclampsia
12/07/2010CA2264925C Purification of antigen-specific t cells
12/02/2010WO2010138522A2 Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
12/02/2010WO2010138486A1 Substrates for adhering, culturing and assaying cells
12/02/2010WO2010136617A1 Polymeric conjugate for treating bacterial infections
12/02/2010WO2010135800A1 Inhibiting oxidation and immobilizing biomolecules on a hydrogen-terminated crystalline silicon substrate
12/02/2010WO2010115835A3 Stabilizing composition for immobilized biomolecules
12/02/2010US20100305309 Nanodiamond particle complexes
12/02/2010US20100305033 Hydroxyalkyl starch derivatives and process for their preparation
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010CA2763074A1 Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
12/01/2010EP1373301B1 Reducing the immunogenicity of fusion proteins
12/01/2010CN101407549B Method for modifying antibody on gold film of micro-cantilever beam
11/2010
11/30/2010US7842784 Antagonizing bone morphogenetic protein activity; utilizing polypeptide comprising amino acids 22-452 of sequence 8; bone diseases, tissue regeneration, wound healing
11/30/2010US7842783 Mouse spermatogenesis genes related to human male sterility
11/30/2010US7842280 solid phase peptide synthesis for a peptidyl contrast agent; synthesizing an amino-chelator loaded resin coupling the loaded resin to C-terminus and/or backbone of a peptide, cleaving the amino-chelator-peptide from a resin, and chelating a lanthanide metal; DOTA or DTPA chelate coupled to peptide
11/30/2010CA2217053C Method of photochemical immobilization of ligands using quinones
11/25/2010WO2010134084A1 A method of purifying human growth hormone and purified growth hormone thereof
11/25/2010DE102009021681A1 New Staphylococcus aureus-binding peptide, comprising amino acid sections, useful for the enrichment, immobilization, detection and/or marking of Staphylococcus aureus
11/23/2010US7838632 Maize cellulose synthases and uses thereof
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 107